Cadila Healthcare trades higher on the BSE

06 Sep 2021 Evaluate

Cadila Healthcare is currently trading at Rs. 556.40, up by 0.70 points or 0.13% from its previous closing of Rs. 555.70 on the BSE.

The scrip opened at Rs. 556.90 and has touched a high and low of Rs. 557.85 and Rs. 551.45 respectively. So far 99963 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 673.70 on 12-May-2021 and a 52 week low of Rs. 358.10 on 11-Sep-2020.

Last one week high and low of the scrip stood at Rs. 560.95 and Rs. 548.35 respectively. The current market cap of the company is Rs. 56838.19 crore.

The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 15.22% and 9.90% respectively.

Zydus Cadila’s Sitagliptin base tablets has received tentative approval from the United States Food and Drug Administration (USFDA) for its new drug application for Sitagliptin base 25, 50 and 100 mg tablets. Zydus’ Sitagliptin base contains the active moiety Sitagliptin in a different form than used in the branded reference product, Januvia (Sitagliptin Phosphate).

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

953.50 20.10 (2.15%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.